Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Entourage Health Corp V.ENTG

Alternate Symbol(s):  ETRGF

Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of brands in the Canadian market, including its brand Color Cannabis, mainstream brand Saturday Cannabis, medical cannabis product brand Starseed Medicinal and its craft cannabis brand Syndicate Cannabis. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including oils, capsules, soft chews, topicals, beverages and vapes, for sale in both the medical and adult-use markets across Canada. Its elite adult-use product portfolio also includes Dime Bag a pre-roll offering, sold across eight provincial distribution agencies.


TSXV:ENTG - Post by User

Bullboard Posts
Post by kijijion Nov 27, 2019 9:25pm
187 Views
Post# 30400557

WMD article

WMD article
One stock you know you can count on, because it’s extremely cheap and the stock has already reached profitability, is WeedMD (TSXV:WMD).
 
WeedMD is a vertically integrated cannabis company that has both cultivation and extraction operations. It also has an ownership stake in Pioneer Cannabis, a retail store in Burlington, Ontario, to complete its vertical integration.
 
It currently has roughly 50,000 kg of cultivation capacity. By 2020, it expects to increase that by 200% to 150,000 kg. The facility it uses for its greenhouse growing has some of the best technology possible, with automated climate control and specific micro climate cultivation rooms.
 
The greenhouse is built right onsite where its outdoor growth production takes place, making it easier for the company logistically to distribute and manage its products.
 
Its extraction capacity has also been growing, as the company scales the operations of its facility, on the way to its goal of 200,000 kg of annual capacity.
 
To date, it has made six different distribution agreements with provinces from B.C. to Ontario and Nova Scotia. It’s diversified its distribution though, adding deals with pharmacies as well as its direct-to-consumer distribution.
 
In addition, WeedMD is the first and only licensed producer (LP) to make multiple supply deals with long-term-care providers.
 
Like many peers in the industry, it has also diversified with some international exposure, becoming the first LP to sell and export genetics to Australia and Israel.
 
What makes WeedMD the most compelling, though, is its valuation. The stock may be the cheapest cannabis company in Canada.
 
For starters, its price to earnings, which many of its peers can’t be measured against because they aren’t profitable like WeedMD, is only slightly more than 10 times.
 
The company’s enterprise value (a measure of the company’s total cost to an investor today) to fully funded annual capacity ratio, one of the top ways to compare cannabis companies, is one of the lowest in the country. Currently, it sits at just one times — extremely low compared to the rest of the industry.
 
The company’s return on equity has been a little more than 15% compared to the average of the rest of the industry which still sits in negative territory.
 
It has one of the lowest market caps in Canada at just $125 million, yet it has the fifth-highest funded capacity of all licensed producers.
 
Clearly, there is a disconnect here, and worst-case scenario, if the entire sector is still overvalued, intuitively, WeedMD will fall the least given its extremely cheap valuation already, which gives investors a large margin of safety.
 
If you have been considering the cannabis stocks recently, especially after this massive sell-off, I would start with WeedMD, the cheapest stock by far.
 
It’s reporting earnings after the market closes on Thursday, so we can get a better glimpse into how its performance has been going.
Bullboard Posts